A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion
Clinical trial NCT07649369 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07649369
- Sponsor
- Shanghai Jeyou Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-17
- Primary completion
- 2028-01-12
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.